Skip to main content

Table 1 Overview of subject characteristics (n = 50)

From: Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings

 

N

%

Age group at screening, years

  

   50-59

25

50.0

   60-69

13

26.0

   70-79

12

24.0

Ethnicity

  

   White

42

84.0

   Black

5

10.0

   Hispanic

3

6.0

Hormone replacement therapy use

  

   Never used

26

52.0

   Past user

19

38.0

   Current user

5

10.0

Hormone replacement therapy duration, years

  

   <5

16

66.7

   5 to <10

3

12.5

   10+

5

20.8

Body mass index (BMI), kg/m2

  

   <25

6

12.2

   25 to <30

18

36.7

   ≥30

25

51.0

BMI at year 1

  

   <25

3

6.1

   25 to <30

21

42.9

   ≥30

25

51.0

Smoking

  

   Never smoked

29

58.0

   Past smoker

19

38.0

   Current smoker

2

4.0

Parity

  

   Never pregnant/no term pregnancy

4

8.0

   ≥1 term pregnancy

46

92.0

Age at first birth, years

  

   <20

15

34.1

   20-29

27

61.4

   30+

2

4.5

Age at hysterectomy, years

  

   <40

19

38.0

   40-49

18

36.0

   50-54

6

12.0

   55+

7

14.0

Prior bilateral oophorectomy

  

   No

33

71.7

   Yes

13

28.3

Treated diabetes

  

   No

43

86.0

   Yes

7

14.0

Treated for hypertension or blood pressure ≥140/90 mmHg

  

   No

29

63.0

   Yes

17

37.0

History of high cholesterol requiring pills

  

   No

42

95.5

   Yes

2

4.5

Statin use at baseline

  

   No

48

96.0

   Yes

2

4.0

Aspirin (≥80 mg) use at baseline

  

   No

42

84.0

   Yes

8

16.0

History of myocardial infarction

  

   No

50

100.0

History of angina

  

   No

47

94.0

   Yes

3

6.0

History of coronary artery bypass graft/percutaneous transluminal coronary angioplasty

  

   No

47

100.0

History of stroke

  

   No

50

100.0

History of deep vein thrombosis or pulmonary embolism

  

   No

50

100.0

Family history of breast cancer (female)

  

   No

41

85.4

   Yes

7

14.6

History of fracture on/after age 55

  

   No

31

96.9

   Yes

1

3.1

Gail Model five year risk of breast cancer

  

   <1

10

20.0

   1 to <2

34

68.0

   2 to <5

6

12.0

Number of falls in last 12 months

  

   None

30

69.8

   1

7

16.3

   2

6

14.0